Fig. 1From: Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): update and insights into current practices and future directions for research and implementationGraph depicting total number of resuscitative endovascular balloon occlusion of the aorta (REBOA) cases per year based on literature review of human and animal studies. Arrows denote the years 2011, when the REBOA prototype was developed, and 2016, in which the REBOA-ER® was cleared by the U.S. Food and Drug Administration. Data generated using original human and animal REBOA studies published in the literature with exception of databases with overlapping sourcesBack to article page